Maternal and perinatal outcomes of pregnancies in systemic lupus erythematosus: A nationwide population-based study

被引:35
作者
Chen, Yen-Ju [1 ]
Chang, Jui-Chun [2 ,3 ]
Lai, Ee-Ling [1 ,4 ]
Liao, Tsai-Ling [5 ,6 ,7 ]
Chen, Hsin-Hua [1 ,5 ,6 ,7 ,8 ]
Hung, Wei-Ting [1 ,9 ]
Hsieh, Tsu-Yi [1 ,9 ]
Huang, Wen-Nan [1 ,8 ]
Chen, Yi-Hsing [1 ,8 ]
Lin, Ching-Heng [5 ,10 ,11 ,12 ,13 ,14 ]
Chen, Yi-Ming [1 ,5 ,6 ,7 ,8 ]
机构
[1] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, 1650,Sect 4,Taiwan Blvd, Taichung 407, Taiwan
[2] Taichung Vet Gen Hosp, Dept Obstet & Gynecol, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Womens Hlth, Taichung, Taiwan
[4] Hosp Sultan Ismail, Rheumatol Unit, Johor Baharu, Malaysia
[5] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan
[6] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan
[7] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan
[8] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan
[9] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan
[10] Fu Jen Catholic Univ, Dept Publ Hlth, New Taipei, Taiwan
[11] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan
[12] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan
[13] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan
[14] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan
关键词
Systemic lupus erythematosus; Pregnancy; Maternal outcomes; Fetus; INTRAUTERINE GROWTH RESTRICTION; ANTIRHEUMATIC DRUGS; FETAL OUTCOMES; CHILDREN BORN; WOMEN; HYDROXYCHLOROQUINE; MANAGEMENT; IMPACT; RISK; CLASSIFICATION;
D O I
10.1016/j.semarthrit.2020.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease that develops mainly in women of reproductive age. We aimed to explore the risk of pregnancy complications in Asian patients with SLE. Methods: From January 2005 to December 2014, we conducted a nationwide case-control study, using Taiwan's National Health Insurance Research Database. Obstetric complications and perinatal outcomes in SLE patients were compared with those without SLE. Results: 2059 SLE offspring and 8236 age-matched, maternal healthy controls were enrolled. We found increased obstetric and perinatal complications in SLE population compared with healthy controls. SLE patients exhibited increased risk of preeclampsia/eclampsia (8.98% vs.1.98%, odds ratio [OR]: 3.87, 95% confidence interval [95% CI]: 3.08-4.87, p<0.0001). Their offspring tended to have lower Apgar scores (<7) at both 1 min (10.7% vs. 2.58%, p <0.0001) and 5 min (4.25% vs. 1.17%, p<0.0001), as well as higher rates of intrauterine growth restriction (IUGR, 9.91% vs. 4.12%, OR: 2.24, 95% CI: 1.85-2.71, p<0.0001), preterm birth (23.70% vs 7.56%, OR: 3.00, 95% CI: 2.61-3.45, p<0.0001), and stillbirth (4.23% vs. 0.87%, OR: 3.59, 95% CI: 2.54-5.06, p<0.0001). The risks of preterm birth and stillbirth were markedly increased in SLE patients with concomitant preeclampsia/eclampsia or IUGR. Preterm birth of SLE patients was 1-4 gestational weeks earlier than that of healthy controls and the peak occurrence of stillbirth in SLE population was at 20-30 gestational weeks. Conclusions: Asian SLE patients exhibited increased risks of maternal complications and adverse birth outcomes. Frequent antenatal visits before 20 gestational weeks are recommended in high-risk SLE patients. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:451 / 457
页数:7
相关论文
共 44 条
[1]   EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome [J].
Andreoli, L. ;
Bertsias, G. K. ;
Agmon-Levin, N. ;
Brown, S. ;
Cervera, R. ;
Costedoat-Chalumeau, N. ;
Doria, A. ;
Fischer-Betz, R. ;
Forger, F. ;
Moraes-Fontes, M. F. ;
Khamashta, M. ;
King, J. ;
Lojacono, A. ;
Marchiori, F. ;
Meroni, P. L. ;
Mosca, M. ;
Motta, M. ;
Ostensen, M. ;
Pamfil, C. ;
Raio, L. ;
Schneider, M. ;
Svenungsson, E. ;
Tektonidou, M. ;
Yavuz, S. ;
Boumpas, D. ;
Tincani, A. .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) :476-485
[2]  
[Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2
[3]  
[Anonymous], the presence and severity of weight-related health problems in
[4]   Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls [J].
Barnado, April ;
Wheless, Lee ;
Meyer, Anna K. ;
Gilkeson, Gary S. ;
Kamen, Diane L. .
LUPUS SCIENCE & MEDICINE, 2014, 1 (01)
[5]   The geoepidemiology of systemic lupus erythematosus [J].
Borchers, Andrea T. ;
Naguwa, Stanley M. ;
Shoenfeld, Yehuda ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2010, 9 (05) :A277-A287
[6]   Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016 [J].
Bundhun, Pravesh Kumar ;
Soogund, Mohammad Zafooruddin Sani ;
Huang, Feng .
JOURNAL OF AUTOIMMUNITY, 2017, 79 :17-27
[7]   Predictors of Pregnancy Outcomes in Patients With Lupus A Cohort Study [J].
Buyon, Jill P. ;
Kim, Mimi Y. ;
Guerra, Marta M. ;
Laskin, Carl A. ;
Petri, Michelle ;
Lockshin, Michael D. ;
Sammaritano, Lisa ;
Branch, D. Ware ;
Porter, T. Flint ;
Sawitzke, Allen ;
Merrill, Joan T. ;
Stephenson, Mary D. ;
Cohn, Elisabeth ;
Garabet, Lamya ;
Salmon, Jane E. .
ANNALS OF INTERNAL MEDICINE, 2015, 163 (03) :153-+
[8]   The continuing value of the apgar score for the assessment of newborn infants. [J].
Casey, BM ;
McIntire, DD ;
Leveno, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :467-471
[9]   Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study [J].
Chen, Yi-Ming ;
Lin, Ching-Heng ;
Lan, Tsuo-Hung ;
Chen, Hsin-Hua ;
Chang, Shih-Ni ;
Chen, Yi-Hsing ;
Wang, Jun-Sing ;
Hung, Wei-Ting ;
Lan, Joung-Liang ;
Chen, Der-Yuan .
RHEUMATOLOGY, 2015, 54 (07) :1244-1249
[10]  
Clark CA, 2005, J RHEUMATOL, V32, P1709